首页 › 前列腺癌 › 得克萨斯州 › Richardson
Richardson TX 前列腺癌临床试验
6项针对 前列腺癌的研究正在 Richardson及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
招募中3 期
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- University of Texas Southwestern Simmons Cancer Center - Richardson/Plano, Richardson
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- UT Southwestern Clinical Center at Richardson/Plano, Richardson
其他城市的 前列腺癌试验
- New York City, NY101 项研究
- Houston, TX73 项研究
- Los Angeles, CA64 项研究
- Boston, MA56 项研究
- Seattle, WA45 项研究
- St. Louis, MO45 项研究
- Chicago, IL45 项研究
- Baltimore, MD45 项研究
- San Francisco, CA44 项研究
- Philadelphia, PA41 项研究
- Nashville, TN40 项研究
- Washington, DC39 项研究
Richardson的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。